Ophthalmic neovascular disease Diabetic retinopathy Retinal vein occlusion
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Ophthalmic neovasular disease 2) Diabetic retinopathy 3) Retinal vein occlusion 4) Patient 20 years or older at the time of the agreement acquisition 5) The patient that understands this study enough and the agreement in the document by the free will was provided after having received enough explanation
Exclusion criteria
Exclusion criteria: 1) The patient who has difficulty in observation of the fundus for high cataract, corneal clouding 2) Patient younger than 20 years 3) The patient who received other study medication or other clinical experimental medicine within three months before this medication start 4) In addition, the patient who judged an examination responsibility (allotment) doctor to be inappropriate as a subject
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ocular fundus | — |
Secondary
| Measure | Time frame |
|---|---|
| Visual acuity Optical coherence tomography Fluorescein angiography Improvement of visual field Improvement of intraocular pressure | — |
Countries
Japan
Contacts
Chiba University Graduate School of Medicine Department of Ophthalmology and Visual Science